These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15972661)

  • 1. Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice.
    Allison J; Thomas HE; Catterall T; Kay TW; Strasser A
    J Immunol; 2005 Jul; 175(1):293-301. PubMed ID: 15972661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Fas ligand in beta cell destruction in autoimmune diabetes of NOD mice.
    Petrovsky N; Silva D; Socha L; Slattery R; Charlton B
    Ann N Y Acad Sci; 2002 Apr; 958():204-8. PubMed ID: 12021107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
    Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
    J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
    Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
    J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
    Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
    J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice.
    Augstein P; Heinke P; Salzsieder E; Berg S; Rettig R; Salzsieder C; Harrison LC
    Endocrinology; 2004 Jun; 145(6):2747-52. PubMed ID: 15033908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Redd S; Ginn S; Ross JM
    Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
    Thomas HE; Darwiche R; Corbett JA; Kay TW
    J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
    Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
    J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
    Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC
    J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways.
    Dudek NL; Thomas HE; Mariana L; Sutherland RM; Allison J; Estella E; Angstetra E; Trapani JA; Santamaria P; Lew AM; Kay TW
    Diabetes; 2006 Sep; 55(9):2412-8. PubMed ID: 16936188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
    Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
    J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Fas in autoimmune diabetes.
    Chervonsky AV; Wang Y; Wong FS; Visintin I; Flavell RA; Janeway CA; Matis LA
    Cell; 1997 Apr; 89(1):17-24. PubMed ID: 9094710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
    Suarez-Pinzon W; Sorensen O; Bleackley RC; Elliott JF; Rajotte RV; Rabinovitch A
    Diabetes; 1999 Jan; 48(1):21-8. PubMed ID: 9892218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.
    Amrani A; Verdaguer J; Anderson B; Utsugi T; Bou S; Santamaria P
    J Clin Invest; 1999 Apr; 103(8):1201-9. PubMed ID: 10207172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice.
    Darwiche R; Chong MM; Santamaria P; Thomas HE; Kay TW
    J Immunol; 2003 Jun; 170(12):6292-7. PubMed ID: 12794162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL.
    McKenzie MD; Dudek NL; Mariana L; Chong MM; Trapani JA; Kay TW; Thomas HE
    Int Immunol; 2006 Jun; 18(6):837-46. PubMed ID: 16574667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 receptor deficiency slows progression to diabetes in the NOD mouse.
    Thomas HE; Irawaty W; Darwiche R; Brodnicki TC; Santamaria P; Allison J; Kay TW
    Diabetes; 2004 Jan; 53(1):113-21. PubMed ID: 14693705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.